|Articles|July 30, 2015
Video: CFO Simon Dingemans on GSK's Q2 Results
July 30, 2015.
Advertisement
In this video
, GlaxoSmithKline CFO Simon Dingemans relays the company's Q2 2015 results, rhe first since the Novartis transaction closed. Despite a slide in the sales of lung drug Advair and lower profit margins following a business revamp, Dingemans says sales rose during the period and that newly acquired businesses are performing in line with expectations.
http://www.3bnexus.com/portal/video/6hdb24abf34c8cc
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Artisan Partners’ Director Calls for Novartis Board Shake-Up
2
340B Under Pressure: Inside Pharma's Push for Greater Clarity
3
The Agentic AI Revolution in Biopharma
4
Kura Oncology Spins Out Caspian Therapeutics With $50 Million to Test Menin Inhibition as a Disease-Modifying Approach to Diabetes
5